Stage I/II Hodgkin's disease (HD) with bulky mediastinal disease or other risk factors (RF) the Stanford V experience

被引：0
|
作者：
Advani, R. H. [1 ]
Hoppe, R. T. [1 ]
Rosenberg, S. A. [1 ]
Horning, S. J. [1 ]
机构：
[1] Stanford Univ, Ctr Canc, Stanford, CA 94305 USA
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：27 / 27
页数：1
相关论文
共 50 条
  • [1] Prognostic factors for advanced stage Hodgkin's disease (HD)
    Vassilakopoulos, TP
    Barbounis, A
    Angelopoulou, MK
    Boussiotis, VA
    Hatziioannou, M
    Kontopidou, F
    Fessas, P
    Kittas, C
    Pangalis, GA
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 411 - 411
  • [2] Brief chemotherapy (Stanford V) and adjuvant radiotherapy for bulky or advanced Hodgkin's disease: An update
    Horning, SJ
    Rosenberg, SA
    Hoppe, RT
    ANNALS OF ONCOLOGY, 1996, 7 : 105 - 108
  • [3] Outcome of Bulky mediastinal Hodgkin's disease patients.
    Johnson, N
    Lambert, C
    Vuong, T
    Lachance, S
    BLOOD, 2001, 98 (11) : 243B - 243B
  • [4] Th use of stanford v overcomes poor prognostic features in patients with advanced stage Hodgkin's disease (HD).
    Moskowitz, CH
    Yahalom, J
    Straus, D
    Portlock, CS
    Goy, A
    O'Brien, JP
    Zelenetz, AD
    BLOOD, 1998, 92 (10) : 625A - 625A
  • [5] Stanford V regimen plus consolidative radiotherapy is an effective therapeutic program for bulky or advanced-stage Hodgkin's disease
    Aversa, SML
    Salvagno, L
    Sorarù, M
    Mazzarotto, R
    Boso, C
    Gaion, F
    Chiarion-Sileni, V
    De Franchis, G
    Favaretto, AG
    Crivellari, G
    Banna, GL
    Sotti, G
    Monfardini, S
    ACTA HAEMATOLOGICA, 2004, 112 (03) : 141 - 147
  • [6] Assessment of favorable (F) versus unfavorable (U) early stage Hodgkin's disease (HD); the Stanford V plus radiotherapy (RT) experience.
    Advani, R
    Maeda, L
    Hoppe, RT
    Breslin, S
    Rosenberg, SA
    Baer, D
    Mason, J
    Horning, SJ
    BLOOD, 2005, 106 (11) : 548A - 548A
  • [7] Bulky mediastinum in advanced Hodgkin's disease (HD): Is there rationale for stratification?
    Bogatyreva, T
    Afanasova, N
    Danilenko, A
    Pavlov, V
    ANNALS OF ONCOLOGY, 1998, 9 : 113 - 114
  • [8] Reproductive risk factors for Hodgkin's disease (HD) in women.
    Glaser, S
    Stearns, C
    Clarke, C
    Nugent, R
    Dorfman, R
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S205 - S205
  • [9] REEVALUATION OF PROGNOSIS IN STAGE-I AND STAGE-II HODGKINS-DISEASE WITH BULKY MEDIASTINAL INVOLVEMENT
    GHERLINZONI, F
    ZINZANI, PL
    LAURIA, F
    MAZZA, P
    BARBIERI, E
    EMILIANI, E
    FIACCHINI, M
    NERI, S
    POLETTI, G
    TURA, S
    HAEMATOLOGICA, 1987, 72 (03) : 237 - 239
  • [10] STAGE I-IIIA NON-BULKY HODGKIN'S LYMPHOMA. IS FURTHER DISTINCTION BASED ON PROGNOSTIC FACTORS USEFUL? THE STANFORD EXPERIENCE
    Advani, Ranjana H.
    Hoppe, Richard T.
    Maeda, Lauren S.
    Baer, David M.
    Mason, Joseph
    Rosenberg, Saul A.
    Horning, Sandra J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (05): : 1374 - 1379
12345